FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Antimony drug compound A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antimony sodium stibogluconate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antimuscarinic A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antimuscarinic agent used in parkinsonism A component that fails to comply with the current editorial guidance.
Antimuscarinic allergy A component that fails to comply with the current editorial guidance.
Antimuscarinic drug used in parkinsonism A component that fails to comply with the current editorial guidance.
Antimycobacterial antibiotic poisoning A component that fails to comply with the current editorial guidance.
Antimycobacterial antibiotic poisoning NOS A component that fails to comply with the current editorial guidance.
Antimycobacterial drug poisoning NOS A component that fails to comply with the current editorial guidance.
Antineoplastic alkaloid A component that fails to comply with the current editorial guidance.
Antineoplastic alkaloid A component that is no longer current, useful, appropriate or acceptable.
Antineoplastic anthraquinone A component that fails to comply with the current editorial guidance.
Antineoplastic antibiotic A component that fails to comply with the current editorial guidance.
Antineoplastic antibiotic poisoning NOS A component that fails to comply with the current editorial guidance.
Antineoplastic chemotherapy regimen A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antineoplastic metal complex agent A component that fails to comply with the current editorial guidance.
Antineoplastic metal complex preparation A component that fails to comply with the current editorial guidance.
Antineoplastic or immunosuppressive Ambiguous
Antineoplastic or immunosuppressive poisoning NOS A component that fails to comply with the current editorial guidance.
Antineoplastic poisoning A component that fails to comply with the current editorial guidance.
Antineoplastic vinca alkaloid A component that fails to comply with the current editorial guidance.
Antineoplastic, immunosuppressant and immunostimulant Ambiguous
Antineutrophil cytoplasmic antibody positive A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antiparasite agent A component that fails to comply with the current editorial guidance.
Antiparasite drug A component that fails to comply with the current editorial guidance.
Antiparkinsonian drug poisoning NOS A component that fails to comply with the current editorial guidance.
Antiperspirant Ambiguous
Antiphlogistic agent A component that fails to comply with the current editorial guidance.
Antiphobic therapy A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antiphospholipid syndrome A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antiplatelet agent Ambiguous
Antiplatelet agent therapy Ambiguous
Antiplatelet aspirin Ambiguous
Antiplatelet therapeutic role Erroneous component (foundation metadata concept)
Antiplatelet therapy contraindicated Ambiguous
Antiprotozoal drug A component that fails to comply with the current editorial guidance.
Antiprotozoal drug poisoning NOS A component that fails to comply with the current editorial guidance.
Antipruritic topical anesthetic A component that fails to comply with the current editorial guidance.
Antipsychotic drug A component that fails to comply with the current editorial guidance.
Antipyretic A component that fails to comply with the current editorial guidance.
Antipyretic poisoning A component that fails to comply with the current editorial guidance.
Antipyretic poisoning, NEC A component that fails to comply with the current editorial guidance.
Antipyretic poisoning, NEC A component that fails to comply with the current editorial guidance.
Antipyrine + benzocaine + glycerin 54mg/14mg/1cc solution A component that is no longer current, useful, appropriate or acceptable.
Antipyrine + benzocaine 5.4%wv/1.442%wv solution A component that is no longer current, useful, appropriate or acceptable.
Antireflux operation NOS Limited component (foundation metadata concept)
Antireflux operation using thoracic approach NEC Limited component (foundation metadata concept)
Antireflux operation: [gastropexy (& Hill)] or [gastroplasty] Ambiguous
Antireflux operations Ambiguous
Antireflux procedure and gastroplasty however further qualified Limited component (foundation metadata concept)
Antirheumatic poisoning NOS Limited component (foundation metadata concept)
Antirheumatic poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antischistosomal Ambiguous
Antischistosomal drug A component that fails to comply with the current editorial guidance.
Antiseborrheic agent A component that fails to comply with the current editorial guidance.
Antisera allergy A component that fails to comply with the current editorial guidance.
Antisera overdose Ambiguous
Antisera overdose of undetermined intent Ambiguous
Antisera poisoning Moved elsewhere
Antisera poisoning of undetermined intent Moved elsewhere
Antiserum AND/OR toxoid A component that fails to comply with the current editorial guidance.
Antispasmodic homatropine A component that fails to comply with the current editorial guidance.
Antispasmodic overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antispasmodic poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antispasmodics and other drugs altering gut motility A component that fails to comply with the current editorial guidance.
Antistreptolysin O antibody titre A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antistreptolysin O screen Ambiguous
Antistreptolysin-O titer test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antithrombin Ambiguous
Antithrombin II A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antithrombin III 1000iu injection solution A component that fails to comply with the current editorial guidance.
Antithrombin III 250iu injection solution A component that fails to comply with the current editorial guidance.
Antithrombin III 500iu injection solution A component that fails to comply with the current editorial guidance.
Antithrombin III 600iu injection (pdr for recon) Erroneous component (foundation metadata concept)
Antithrombin III 600iu injection (pdr for recon) Erroneous component (foundation metadata concept)
Antithrombin III level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antithrombin III preparation A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antithrombin III product A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antithrombin III, heparin cofactor assay Ambiguous
Antithyroid agent poisoning NOS A component that fails to comply with the current editorial guidance.
Antithyroid drug allergy A component that fails to comply with the current editorial guidance.
Antitoxin (animal) Moved elsewhere
Antitreponemal agent Ambiguous
Antitrichomonal Ambiguous
Antitrypanosomal Ambiguous
Antitrypanosomal drug A component that fails to comply with the current editorial guidance.
Antituberculous drugs A component that fails to comply with the current editorial guidance.
Antitussive poisoning NOS A component that fails to comply with the current editorial guidance.
Antivaricose agent allergy A component that fails to comply with the current editorial guidance.
Antivaricose drug A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antivaricose drug poisoning A component that fails to comply with the current editorial guidance.
Antivaricose drug poisoning NOS A component that fails to comply with the current editorial guidance.
Antiviral drug poisoning NOS A component that fails to comply with the current editorial guidance.
Antiviral preparations A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antixerostomia therapeutic role Ambiguous
Antler structure Moved elsewhere
Antral washings Ambiguous
Antrochoanal polyp A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antrochoanal polyp A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antwerp bearded bantam Moved elsewhere
Anulus fibrosus of intervertebral disc of eighteenth thoracic vertebra Moved elsewhere

Start Previous Page 121 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start